← Back to Clinical Trials
Recruiting NCT06987474

NCT06987474 Capella Scientia Development Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06987474
Status Recruiting
Phase —
Sponsor Alcon Research
Condition Cataract
Study Type OBSERVATIONAL
Enrollment 400 participants
Start Date 2025-07-30
Primary Completion 2027-05

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Unity DX and SMARTCataract DX (SCDX) BiometerIOLMaster 700 BiometerArgos with Alcon Image Guidance Biometer

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 400 participants in total. It began in 2025-07-30 with a primary completion date of 2027-05.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study involves collecting biometry and aberration data using the next generation biometer, Unity DX.

Eligibility Criteria

Inclusion Criteria: * Able to understand and sign an IRB/IEC approved consent form; * Willing and able to attend study visit(s) as required by the protocol; * Consenting age at the jurisdiction of study site; * Other group-specific, protocol required inclusion criteria may apply. Exclusion Criteria: * Women of child-bearing potential; * Unable to fixate due to nystagmus or other eye movement abnormality (e.g., significant strabismus); * Unclear optical media preventing data capture from all devices in the study; * Contraindicated for pupil dilation (e.g., narrow angles, allergies) per investigator's clinical judgment; * Any ocular disease and/or condition that, in the investigator's clinical judgment, may put the subject at significant risk, may compromise study results, or may interfere significantly with the subject's participation in the study; * Other group-specific, protocol required exclusion criteria may apply.

Contact & Investigator

Central Contact

Alcon Call Center

✉ alcon.medinfo@alcon.com

📞 1-888-451-3937

Principal Investigator

Principal II, Clinical Trial Operations, Vision Care

STUDY DIRECTOR

Alcon Research, LLC

Frequently Asked Questions

Who can join the NCT06987474 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Cataract. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06987474 currently recruiting?

Yes, NCT06987474 is actively recruiting participants. Contact the research team at alcon.medinfo@alcon.com for enrollment information.

Where is the NCT06987474 trial being conducted?

This trial is being conducted at Salt Lake City, United States, Bangalore, India, Makati City, Philippines, Madrid, Spain and 1 additional location.

Who is sponsoring the NCT06987474 clinical trial?

NCT06987474 is sponsored by Alcon Research. The principal investigator is Principal II, Clinical Trial Operations, Vision Care at Alcon Research, LLC. The trial plans to enroll 400 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology